Oxabenz 50 Injection
Marketer
Admac Pharma Ltd
Salt Composition
Oxaliplatin (2mg/ml)
Overview Oxabenz 50 Injection
Colorectal cancer is treated with Oxabenz 50 Injection, a medication that inhibits or reduces the proliferation of cancerous cells. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician, varying based on your condition. Strict adherence to your doctor's prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse reactions. While therapeutic effects might not be immediately apparent (taking several weeks or months), discontinuation should only occur under medical supervision. Common side effects include nausea, tiredness, vomiting, and diarrhea. Oxabenz 50 Injection can decrease blood cell counts (red and white), potentially increasing infection risk. Severe allergic reactions, such as mouth sores, rashes, itching, or breathing difficulties, necessitate immediate medical attention. Regular blood tests monitoring blood cell levels, along with heart, liver, and uric acid levels, are essential. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, or concurrent medication use, especially antibiotics. Drug interactions are possible; inform your medical team of all medications you're taking. This medication is contraindicated during pregnancy and breastfeeding. Male infertility is a potential side effect; sperm preservation should be discussed with your doctor before treatment commences. Post-injection dizziness may impair driving ability.
Uses of Oxabenz 50 Injection
Colorectal cancer
Major Benefits of Oxabenz 50 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Oxabenz 50 Injection:
- Nausea
- Fatigue
- Anemia (low number of red blood cells)
- Vomiting
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Low blood platelets
- Increased liver enzymes
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Stomatitis (Inflammation of the mouth)
How to use Oxabenz 50 Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Oxabenz 50 Injection works:
Oxabenz 50 Injection is a cancer treatment that disrupts the genetic makeup (DNA and RNA) of cancerous cells, thereby halting their proliferation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Oxabenz 50 Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Oxabenz 50 Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Oxabenz 50 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be impaired by side effects of Oxabenz 50 Injection. Oxaliplatin therapy increases the likelihood of dizziness, nausea, vomiting, and other neurological symptoms impacting gait, potentially affecting the ability to drive safely.
KidneyCAUTION
For individuals with severely impaired kidney function, Oxabenz 50 Injection requires careful administration and potential dose modification. Consult a physician for guidance. Data regarding Oxabenz 50 Injection use in such patients is limited. Dosage alteration isn't advised for those with mildly or moderately affected kidneys.
LiverCAUTION
For individuals with liver impairment, Oxabenz 50 Injection requires careful administration. Dosage modification of Oxabenz 50 Injection might be necessary. Physician consultation is advised.
What if you forget to take Oxabenz 50 Injection :
Omit a dose of Oxabenz 50 Injection? Seek your physician's advice.
Facts to Know About Oxabenz 50 Injection
| Label | Value |
|---|---|
| Type of Compound | Platinum-based compounds |
| Addictive | None. |
| Medication Classification | Cancer therapies |
| Mechanism of Action | Platinum-based anti-neoplastic agents |
3,018 People bought this recently